158 related articles for article (PubMed ID: 33237763)
1. Purification of Recombinant α-synuclein: A Comparison of Commonly Used Protocols.
Stephens AD; Matak-Vinkovic D; Fernandez-Villegas A; Kaminski Schierle GS
Biochemistry; 2020 Dec; 59(48):4563-4572. PubMed ID: 33237763
[TBL] [Abstract][Full Text] [Related]
2. Purification of α-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity.
Luth ES; Bartels T; Dettmer U; Kim NC; Selkoe DJ
Biochemistry; 2015 Jan; 54(2):279-92. PubMed ID: 25490121
[TBL] [Abstract][Full Text] [Related]
3. Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity.
Stephens AD; Zacharopoulou M; Moons R; Fusco G; Seetaloo N; Chiki A; Woodhams PJ; Mela I; Lashuel HA; Phillips JJ; De Simone A; Sobott F; Schierle GSK
Nat Commun; 2020 Jun; 11(1):2820. PubMed ID: 32499486
[TBL] [Abstract][Full Text] [Related]
4. Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
Illes-Toth E; Ramos MR; Cappai R; Dalton C; Smith DP
Biochem J; 2015 Jun; 468(3):485-93. PubMed ID: 25851527
[TBL] [Abstract][Full Text] [Related]
5. Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain.
Coelho-Cerqueira E; de Araújo Correia Campos C; Follmer C
Biochem Biophys Res Commun; 2019 Feb; 509(2):367-372. PubMed ID: 30591215
[TBL] [Abstract][Full Text] [Related]
6. Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight.
Al-Azzani M; König A; Outeiro TF
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204823
[TBL] [Abstract][Full Text] [Related]
7. Isolation of recombinant tetrameric N-acetylated α-synuclein.
Fernández RD; Lucas HR
Protein Expr Purif; 2018 Dec; 152():146-154. PubMed ID: 30041032
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Expression and Purification of N-Acetylated Alpha-Synuclein.
Eastwood TA; Mulvihill DP
Methods Mol Biol; 2019; 1948():113-121. PubMed ID: 30771174
[TBL] [Abstract][Full Text] [Related]
9. Expression and Purification of Intrinsically Disordered Aβ Peptide and Setup of Reproducible Aggregation Kinetics Experiment.
Linse S
Methods Mol Biol; 2020; 2141():731-754. PubMed ID: 32696387
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies.
Masaracchia C; König A; Valiente-Gabioud AA; Peralta P; Favretto F; Strohäker T; Lázaro DF; Zweckstetter M; Fernandez CO; Outeiro TF
Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140298. PubMed ID: 31676453
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.
Fauvet B; Mbefo MK; Fares MB; Desobry C; Michael S; Ardah MT; Tsika E; Coune P; Prudent M; Lion N; Eliezer D; Moore DJ; Schneider B; Aebischer P; El-Agnaf OM; Masliah E; Lashuel HA
J Biol Chem; 2012 May; 287(19):15345-64. PubMed ID: 22315227
[TBL] [Abstract][Full Text] [Related]
12. Expression, fermentation and purification of a predicted intrinsically disordered region of the transcription factor, NFAT5.
DuMond JF; He Y; Burg MB; Ferraris JD
Protein Expr Purif; 2015 Nov; 115():141-5. PubMed ID: 26256058
[TBL] [Abstract][Full Text] [Related]
13. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160
[TBL] [Abstract][Full Text] [Related]
14. Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.
Ysselstein D; Joshi M; Mishra V; Griggs AM; Asiago JM; McCabe GP; Stanciu LA; Post CB; Rochet JC
Neurobiol Dis; 2015 Jul; 79():150-63. PubMed ID: 25931201
[TBL] [Abstract][Full Text] [Related]
15. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
Mason RJ; Paskins AR; Dalton CF; Smith DP
Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
[TBL] [Abstract][Full Text] [Related]
16. Separation and determination of alpha-synuclein monomeric and oligomeric species using two electrophoretic approaches.
Napp A; Houbart V; Demelenne A; Merville MP; Crommen J; Dumoulin M; Garraux G; Servais AC; Fillet M
Electrophoresis; 2018 Dec; 39(23):3022-3031. PubMed ID: 30157293
[TBL] [Abstract][Full Text] [Related]
17. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
[TBL] [Abstract][Full Text] [Related]
18. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.
Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083
[TBL] [Abstract][Full Text] [Related]
19. A method of purifying alpha-synuclein in
Kamboj S; Harms C; Kumar L; Creamer D; West C; Klein-Seetharaman J; Sarkar SK
Heliyon; 2021 Jan; 7(1):e05874. PubMed ID: 33490665
[TBL] [Abstract][Full Text] [Related]
20. Preparation of soluble proteins from Escherichia coli.
Wingfield PT
Curr Protoc Protein Sci; 2005 Sep; Chapter 6():6.2.1-6.2.22. PubMed ID: 18429289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
